369 related articles for article (PubMed ID: 25267615)
1. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.
Liang M; Fan K; Zhou M; Duan D; Zheng J; Yang D; Feng J; Yan X
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14900-5. PubMed ID: 25267615
[TBL] [Abstract][Full Text] [Related]
2. GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy.
Jiang B; Zhang R; Zhang J; Hou Y; Chen X; Zhou M; Tian X; Hao C; Fan K; Yan X
Theranostics; 2019; 9(8):2167-2182. PubMed ID: 31149036
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
4. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
[TBL] [Abstract][Full Text] [Related]
5. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
[TBL] [Abstract][Full Text] [Related]
6. Ferritin nanocages for early theranostics of tumors via inflammation-enhanced active targeting.
Jiang B; Jia X; Ji T; Zhou M; He J; Wang K; Tian J; Yan X; Fan K
Sci China Life Sci; 2022 Feb; 65(2):328-340. PubMed ID: 34482518
[TBL] [Abstract][Full Text] [Related]
7. High hydrostatic pressure encapsulation of doxorubicin in ferritin nanocages with enhanced efficiency.
Wang Q; Zhang C; Liu L; Li Z; Guo F; Li X; Luo J; Zhao D; Liu Y; Su Z
J Biotechnol; 2017 Jul; 254():34-42. PubMed ID: 28591619
[TBL] [Abstract][Full Text] [Related]
8. CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.
Mondal L; Mukherjee B; Das K; Bhattacharya S; Dutta D; Chakraborty S; Pal MM; Gaonkar RH; Debnath MC
Int J Nanomedicine; 2019; 14():8073-8094. PubMed ID: 31632019
[TBL] [Abstract][Full Text] [Related]
9. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract][Full Text] [Related]
10. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery.
Song N; Zhang J; Zhai J; Hong J; Yuan C; Liang M
Acc Chem Res; 2021 Sep; 54(17):3313-3325. PubMed ID: 34415728
[TBL] [Abstract][Full Text] [Related]
11. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
14. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
15. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
16. Mechanism Study of Thermally Induced Anti-Tumor Drug Loading to Engineered Human Heavy-Chain Ferritin Nanocages Aided by Computational Analysis.
Yin S; Liu Y; Dai S; Zhang B; Qu Y; Zhang Y; Choe WS; Bi J
Biosensors (Basel); 2021 Nov; 11(11):. PubMed ID: 34821660
[TBL] [Abstract][Full Text] [Related]
17. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
[TBL] [Abstract][Full Text] [Related]
18. Response of pH-Sensitive Doxorubicin Nanoparticles on Complex Tumor Microenvironments by Tailoring Multiple Physicochemical Properties.
Chen H; Luo Q; Wang J; He H; Luo W; Zhang L; Xiao Q; Chen T; Xu X; Niu W; Ke Y; Wang Y
ACS Appl Mater Interfaces; 2020 May; 12(20):22673-22686. PubMed ID: 32337980
[TBL] [Abstract][Full Text] [Related]
19. Mild Acid-Responsive "Nanoenzyme Capsule" Remodeling of the Tumor Microenvironment to Increase Tumor Penetration.
Yao H; Guo X; Zhou H; Ren J; Li Y; Duan S; Gong X; Du B
ACS Appl Mater Interfaces; 2020 May; 12(18):20214-20227. PubMed ID: 32248684
[TBL] [Abstract][Full Text] [Related]
20. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma.
Fan K; Jia X; Zhou M; Wang K; Conde J; He J; Tian J; Yan X
ACS Nano; 2018 May; 12(5):4105-4115. PubMed ID: 29608290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
